HIV

Question 1

Biktarvy

Answer 1

Bictegravir
Emtricitabine
Tenofovir alafenamide

Question 2

Triumeq

Answer 2

Dolutegravir
Abacavir
Lamivudine

Question 3

Truvada

Answer 3

Emtricitabine

Tenofovir disoproxil furmarate

Question 4

Descovy

Answer 4

Emtricitabine

Tenofovir alafenamide

Question 5

Tivicay

Answer 5

Dolutegravir

Question 6

Isentress

Answer 6

Raltegravir

Question 7

Atripla

Answer 7

Efavirenz
Emtricitabine
Tenofovir disoproxil fumarate

Question 8

Stribild

Answer 8

Elvitegravir
Cobicistat
Emtricitabine
Tenofovir disoproxil fumarate

Question 9

Genvoya

Answer 9

Elvitegravir
Cobicistat
Emtricitabine
Tenofovir alafenamide

Question 10

Odefsey

Answer 10

Rilpivirine
Emtricitabine
Tenofovir alafenamide

Question 11

First line tx for HIV

Answer 11

INSTI + 2 NRTIs

Question 12

Which tenofovir is more nephrotoxic and osteo risk

Answer 12

Tenofovir disoproxil fumarate

Question 13

What’s the issue with abacavir

Answer 13

Requires HLA-B*701 testing - hypersensitivity rxns

Question 14

Epzicom

Answer 14

Abacavir

Lamivudine

Question 15

All NRTIs have a warning for what

Answer 15

Hepatomegaly with steatosis

Lactic acidosis

Question 16

Name the NRTIs

Answer 16

Abacavir
Lamivudine 
Tenofovir - both
Emtricitabine 
Zidovudine 
Stavudine (pancreatitis risk)
Didanosine (pancreatitis risk)

Question 17

Name the NNRTIs

Answer 17

Efavirenz (bad CNS effects)

Rilpivirine (with food) (CI with PPIs)

Question 18

Name the INSTIs

Answer 18

Elvitegravir (non-preferred because in combo with cobicistat)
Raltegravir (myopathy risk)
Bictegravir
Dolutegravir

Question 19

Where does Maraviroc work in HIV cycle

Answer 19

Step 1 - inhibits binding to the CCR5 co-receptor on CD4+ cells